I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adjuvant atezolizumab versus placebo for patients with rena..:
Pal, Sumanta Kumar
;
Uzzo, Robert
;
Karam, Jose Antonio
...
The Lancet. 400 (2022) 10358 - p. 1103-1116 , 2022
Link:
https://doi.org/10.1016/s0140-6736(22)01658-0
RT Journal T1
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_s0140-6736(22)01658-0&Exemplar=1&LAN=DE A1 Pal, Sumanta Kumar A1 Uzzo, Robert A1 Karam, Jose Antonio A1 Master, Viraj A A1 Donskov, Frede A1 Suarez, Cristina A1 Albiges, Laurence A1 Rini, Brian A1 Tomita, Yoshihiko A1 Kann, Ariel Galapo A1 Procopio, Giuseppe A1 Massari, Francesco A1 Zibelman, Matthew A1 Antonyan, Igor A1 Huseni, Mahrukh A1 Basu, Debasmita A1 Ci, Bo A1 Leung, William A1 Khan, Omara A1 Dubey, Sarita A1 Bex, Axel PB Elsevier BV YR 2022 SN 0140-6736 JF The Lancet VO 400 IS 10358 SP 1103 OP 1116 LK http://dx.doi.org/https://doi.org/10.1016/s0140-6736(22)01658-0 DO https://doi.org/10.1016/s0140-6736(22)01658-0 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)